chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was provided regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 28-OCT-2011, the patient received the ZOSTAVAX (lot number, dosage and route of administration not provided) for its intended purpose: the prevention of shingles. As a direct result of the ZOSTAVAX, the patient suffered from a shingles outbreak, in addition to chronic pain, rash and lesions to various parts of his body. The patient did not have a shingles outbreak until 18-NOV-2015. As a direct result of ZOSTAVAX, the patient suffered mental and emotional distress due to resulting physical limitations and seriousness of his condition. Further, as a tragic consequence, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. Shingles outbreak was considered to be disabling. Additional information has been requested.
Extreme Exhaustion, Inability to think clearly, dry mouth, tongue swelling, severe headaches, fevers, loss of appetite, insomnia, skin infections, extreme feeling of having the flu every day.
TIA   Symptoms: UNS SYM&SIGN,COGNIT FUNC&AWARE(R419).
pt recv vax;rash on chest,abd,back & legs;flushed face,sore throat,congestion in lungs & low energy level;sx began on 8jan96 & have cont thru present;to MD who felt rxn to MMR;
Horrible fever, shot 1 up to 103,shot 2 102, headache,uncontrollable vomiting,
Mild aches and chills.  Temp 100.4 for part of the day.  Symptoms started about 7AM and chills and aches were over by 4-5 PM.  Temp was 99:4 at bedtime and normal this morning and feel fine today.   Only reactive symptoms after 2nd vaccine.
Mild itchy rash on throat, jaw, mouth area. No raised bumps, as in hives, but reddish skin that looks like sun burn.
Shortly after vaccination, patient started experiencing shortness of breath, closure of airway, itchy/scratchy throat and lips. The first dose of Epipen was given at 10:42AM after symptoms began to progress. EMS arrived at 10:50AM to check out the patient. Patient's SpO2 was >98%, and patient refused to go with EMS personnel. As soon as EMS left, patient began experiencing the same allergic reaction symptoms again so a 2nd dose of EpiPen was given at 10:57AM. The patient's friend then walked out of the store after the patient began feeling better and stated she would take the patient to the hospital for further evaluation.
Patient received one dose of Pfizer vaccine while in the community on 3/25/201.  Patient received on dose of Janssen on 4/28/21. No adverse effects were noted or disclosed  when the patient was consulted on 5/6/2021.
Pain in right arm friday and saturday, noticed redness ans swelling sunday morning and used alcohol and warm packs since.
pupils underwent myosis for several hours after the injection before returning to normal dialation rates. (not sure if this was a side effect or just a shock response to foreign matterials entering the body)  localized soreness in arm for a few days. worse second day than first.  chemical taste in mouth resembling isopropyl alcohol for about an hour or so, starting about 30 minutes after recieving vaccine, i assume this was just some of the sterilizing agent entering the body and getting circulated.  mild head fog in the days following the shot, this seems to have mostly gone away and i cant say with certainty if it is a side effect or was caused by some other factor such as stress.  mood disturbance / depression starting the day of the shot, this one might be completely unrelated, I attended a funeral of a family friend on that day which seems a reasonably likely cause for such, im just listing it because I want to be concise with my reporting of what Ive been experiencing.  mild headache behind the temple on the right side of my head, and behind both eyes.  heightened reaction to concrete allergy, not sure what exactly in concrete/cement i am allegric too possible nickel or chromates as pomphlox seems to fit the description, this has been recurrent for years but after recieving the vaccine a ring of hives formed on my left hand and my feet were the most broken out theyve ever been, i worked with cement 1 day after recieving the shot.  a relatively consistent feeling of coldness, since getting the shot ive felt abnormally cold, sometimes feeling the need for wearing a coat in 80+ degree weather. this is completely abnormal, typically i could wear a tshirt in 50°F weather and a hooded sweatshirt would suffice down into the 20s.  persistent joint pain in almost every joint of my body and the surrounding muscles, feels like it may be in the cartilidge or connective tissue, occasional pains had been experienced before and considered a normal part of life, but this has been relatively constant like an inflammatory response.  sleep cycle disturbance, normally i had abnormal sleeping habbits where being awake for 24+ hours at a time wasnt particularly uncommon (oddly this one seemingly gets worse when i stop drinking caffinated drinks), and it was impossible for me to get to sleep prior to like 2-3 am most nights followed by  sleeping for around 4-10 hours a night on average. however since recieving the shot ive been sleeping a lot more than this and at strange times (for me) like the middle of the afternoon.  fever/constant headache on the side the injection was recieved on has set in after about 2weeks and has been terrible, ive had to take ibuprophen for two days just to function, mild visual hallucinations have also occured in the past couple days mostly spatial distortions where the depth perception isnt working properly, and framerate issues where objects in motion leave a trail momentarily.
Heavy periods lasting 4 weeks with lots of clots. Had to get blood transfusion and DC to clean out thickening on uterus wall
Information has been received from a pharmacist concerning a 47 year old female with no drug reactions/allergies and an unspecified thyroid condition and a history of shingles who on 15-JUN-2007 was vaccinated with Zostavax (Oka/Merck) (657676/0619U).  Concomitant therapy included MENACTRA and CYTOMEL.  On 16-JUN-2007 the patient experienced injection site reaction.  His symptoms were described as "hard to the touch," warmth, redness and swelling.  The swollen injection site was 2.5 inches wide and 3 inches in length.  Its appearance was similar to a bee sting or a spider bite, according to the patient. No lab diagnostic studies were performed.  The patient's injection site reaction persisted.  Additional information has been requested.
Information has been received from a registered nurse concerning a female who was vaccinated with 3 doses of ROTATEQ suspension PO on unknown dates. The nurse stated that after the administration the patient developed the rotavirus. No additional AE information was provided. Therapy with ROTATEQ was stopped. Then the patient recovered from patient developed the rotavirus. No further information is available.
Rash, achy, pruritic at PREVNAR 13 injection site 1 week after administration. Diffuse redness over right delt. warm. Redness extends to anterior right side of chest.
after his mother received her first Pfizer Covid vaccine she developed a rash; Hives were just on her arms and legs/hives started around the injection site; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: not reported), via an unspecified route of administration on Jan2021 as single dose for COVID-19 immunisation. Medical history included cancer. The patient's concomitant medications were not reported. On Feb2021, the patient experienced rash and hives on her arms/legs around the injection site. It was reported as per caller that about one week after his mother received her first Pfizer COVID vaccine, she developed a rash. Caller states that when his mother had the first shot, the hives were just on her arms and legs. The clinical outcome of the events was recovered, on unspecified date in Feb2021.   No follow up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Rash on my torso, arms that itched and burned. I also had burning sensation that went down to my legs but I could not see any rash. It only lasted for approximately 5 days.
Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or treatment details reported.
Pt received incomplete dose of the Booster vaccine. pt attested to being Immunocompromised and did not receive the full dose (0.5ml) of the vaccination. The pt only received the half dose of the vaccine (0.25ml)
Patient received the vaccine on May 5th at 3:45 pm.  She felt okay that afternoon.  When she woke up the next day, she felt nauseated and started throwing up with some diarrhea.  Patient went to school but called to have help picked up at 11:00 am - still not feeling well.  She slept that whole afternoon.  Patient started vomiting again on Sunday 5-11-08.
This spontaneous report was received from a registered nurse referring to a 3 month old male patient. There was no pertinent medical history, concurrent conditions, concomitant medication or drug reaction described. On 07-JUL-2016, the patient was vaccinated with improperly stored ROTATEQ lot # L029615, expiration date: 15-MAY-2017, a dose of 2 ml, orally (dose number and frequency were unknown). The vaccine was exposed to an unknown temperature excursion during an unspecified period of time. At the time of reporting there was no adverse event reported. This is one of several reports received from the same reporter. Additional information has been requested.
Lost top 40% of vision field of left eye with slight progression of hazy vision in right side of vision field of left eye. On 7/19/19 He was given high dose dexamethasone therapy for 72 hours, then 7/22/19 he was given a prednisone taper A blood test showed low possibility of inflammatory swelling A retinal scan showed blood vessels not working properly He has had a corotid artery scan. He has another retinal scan scheduled to more specifically analyze his blood vessels. If no answers are found, a possible biopsy of the optic nerve may be needed. He may have future health tests to double check prognosis.
Two weeks after receiving this dose, she saw a small patch of discoloration under her left chin; This spontaneous case was reported by a patient and describes the occurrence of SKIN DISCOLOURATION (Two weeks after receiving this dose, she saw a small patch of discoloration under her left chin) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient never had a COVID positive test or diagnosis. It was reported that no other vaccines were given within 1 month prior to Moderna COVID-19 vaccine. The patient had not experienced a similar event in the past.  Concurrent medical conditions included Lichen planopilaris (pre-existing autoimmune condition, which was a form of alopecia In remission stage,recent status : stable) since 2019 and Allergy (Betadine (cleaning substance used for surgeries)).    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 13-Mar-2021, the patient experienced SKIN DISCOLOURATION (Two weeks after receiving this dose, she saw a small patch of discoloration under her left chin). At the time of the report, SKIN DISCOLOURATION (Two weeks after receiving this dose, she saw a small patch of discoloration under her left chin) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drug was reported. After experiencing skin discoloration, patient did not think much of that and proceeded to receive her second dose of the Moderna vaccine. No treatment was received at the time of dose 1.   This case was linked to MOD-2022-608592 (Patient Link).
Arthritic pains; Rash after receiving Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Arthritic pains) and RASH (Rash after receiving Moderna vaccine) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    No Medical History information was reported.   In May 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 UNK. In 2022, the patient experienced RASH (Rash after receiving Moderna vaccine). On an unknown date, the patient experienced ARTHRALGIA (Arthritic pains). At the time of the report, ARTHRALGIA (Arthritic pains) and RASH (Rash after receiving Moderna vaccine) was resolving.            No concomitant drug reported.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.  The reporter's causality for the event of arthritis pain and rash after receiving Moderna vaccine with HUMIRA (Adalimumab) was no reasonable possibility.  No treatment information was provided by the reporter.
This is a spontaneous report from a contactable consumer. A 22-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# and expiry date: not reported), via an unspecified route of administration, in right arm, on an unspecified date, single dose, for COVID-19 immunization. The patient's medical history included MS (multiple sclerosis), seizures and autism. The patient concomitant medications not reported. Reportedly, patient took oral pill and intravenous medication for MS (he thinks once in a year). The patient historical vaccine included the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot#and expiry date: not reported), via an unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunization. On May 10, 2021, patient experienced 4 nose bleeds since he took the 2nd shot. The reporter wondered was that a normal side effect. On an unspecified date in May 2021, the outcome of the event recovered. Follow-up attempts completed. Information about batch/lot number cannot be obtained.
Received shot on 11/12. On evening 11/19 developed pain and swelling in hands, wrists and left knee. When became painful, saw doctor Thursday afternoon 11/21. Diagnosed as "Reactive Synoidritis, prescribed Zorprin. Severe symptoms until 11/23. Friday evening 11/22 left deltoid swelled.
No adverse event or treatment needed.  On 09/27/2022 our organization did not yet have the bivalent booster, so this patient was given the monovalent dose.   They have been contacted and instructed to get the bivalent booster 2 months after their last dose.
Head pain; Feeling bad; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Head pain) and VACCINATION COMPLICATION (Feeling bad) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Head pain) and VACCINATION COMPLICATION (Feeling bad). At the time of the report, HEADACHE (Head pain) and VACCINATION COMPLICATION (Feeling bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication listed.   No treatment information provided.
Trouble breathing, tightness in chest and severe pain in lower back. Still have lower back pain.
This case was reported by a nurse via sales rep and described the occurrence of stiff neck in a elderly female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX .5 ml. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced stiff neck, pain in arm, headache and blister. On an unknown date, the outcome of the stiff neck, pain in arm and headache were unknown and the outcome of the blister was recovered/resolved. The reporter considered the stiff neck, pain in arm, headache and blister to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not reported. Twenty four hours after receiving vaccination, the patient experienced sore arm, stiff neck and headache. Forty eight hours after receiving vaccination, the patient experienced fluid filled blisters on right leg clearing 5 days later.
pains on her left heart; Fever; Nauseous; loss of appetite; This is a spontaneous report from a contactable consumer or other non hcp (parent). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. Consumer stated that, her daughter had the first shot she just had a sore arm that wasn't anything. The patient experienced pains on her left heart, fever, nauseous and loss of appetite on an unspecified date. The patient underwent lab tests and procedures which included body temperature: unknown results on unknown date. The outcome for the events was unknown.  Information about the Lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100985810 similar report from same reporter
my right shoulder was sore; fatigued; random pains; For three days the bottom of my left foot was moderately painful; This is spontaneous report from a contactable other HCP. This 40-year-old female non-pregnant other HCP reported for herself she received bnt162b2 (BNT162B2) formulation: Solution for injection, dose 2 (Lot Number: EL3302 expiry date was unknown) via an unspecified route of administered in arm left on 26Jan2021 as a single dose for covid-19 immunisation. Medical history included sjogren's syndrome, raynaud's phenomenon, epilepsy from an unknown date and unknown if ongoing. Concomitant medication(s) included lamotrigine taken for an unspecified indication, start and stop date were not reported. Historical vaccine dose 1 product=COVID 19, pfizer/biontech, (lot number=EL 1284 expiry date was unknown) via Intramuscular route of administration at left arm on 05Jan2021 05:45 PM. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient had lamotrigine medications in two weeks. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. Patient had Known allergies with salicylates. She had sjogrens syndrome and over the course of 14 days post 2nd vaccination she developed random pains. For three days the bottom of her left foot was moderately painful; for 3 days her right shoulder was sore even though it was the opposite arm of the vaccination site. She was also very fatigued for 12-24 hours after each dose. Outcome of the events was recovered on an unspecified date.   No follow-up attempts are possible. No further information is expected.
Tinnitus in left ear. Started a few days after receiving my first dose of Moderna covid vaccine.
This is a 14-year-old who received the GARDASIL immunization today and then complained of tingling and numbness after leaving the doctor's office while in the car, drooling and difficulty breathing. When the ambulance was called, she apparently had some stridor and wheezing. She received epinephrine and intravenous BENADRYL and then brought to the Peds ED for evaluation. This patient's symptoms are consistent an allergic reaction probably to the immunization that she received. She received in the ED intravenous SOLU-MEDROL along with ZANTAC and was observed for 3 hours post epinephrine administration. She has had nofurther episodes of wheezing or shortness of breath. She was discharged home with an EPI-PEN to use if needed. BENADRYL and steroid scripts were also given to use twice a day for the next 2 days' time. She is to follow up with her doctor in the morning.
I receivesd the shot at 11;15 A.M.     About 8:30 had a severe nose bleed put ice on it, it stopped in a 45minutes. had sausea also      about 10:00P.M. got the chills shaking all over, went to bed took an Tylenol shook all night. Had chills the next morning and all day, they tapered off in the evening. Have no appitite.
Local pain/stiffness x 2d - general malaise with arthralgia x 2d. Erythematous coalescent macular rash with tenderness. RUE involuntary deltoid muscle and extending down soft tissue to elbow. No fever. No axillary LAD.
Immunizations were given. While nurse turned to put the needle down. Patient passed out on floor. Face down and shook. He stated that he felt warm and then he doesn't remember after that. He came to quickly and responded to questions appropriately. Initially pt stated he bit his tongue and his left knee hurt. No obvious injury to tongue noted. (L) knee has small bruise but pain went away within 15 min. Pt was dizzy when sitting up for a few min and returned to lying down. This persisted for an approximate 45 min - 1 hr. BP and pulse was taken frequently and he was monitored constantly. He was finally about to sit and stand without dizziness or upset stomach and returned to lobby where he remained for approximately 15 min. At 9:27 He was given Hep A #1 to (R) deltoid and then MCV4 to (L) deltoid. He passed out for very short time and woke up talking appropriately. Vision clear. BP 140/70. C/o biting tongue but no obvious injury noted.9:35 BP 120/72 Pulse 72 9:45 70/42 P 52 R: 24. When pt was dizzy he was layed down with legs up until dizziness went away and no c/o sick to stomach. He was sit up to see how he felt. This continued until 10:30. He then sat up and stood without complaints. 9:53 BP 94/58 P -66 9:58 BP 102/96 P - 52 c/o (L) side hurting. Noted 2 inch superficial cut to (L) abd. Slight bleeding. Cleaned with antiseptic wipe then antibiotic creme and bandaid applied. No bruising or hematoma noted. 10:10 108/64 P -64 10:13 BP 112/76 Dad was with patient and he stated that he passes out easy.